JP2025131599A5 - - Google Patents
Info
- Publication number
- JP2025131599A5 JP2025131599A5 JP2025080624A JP2025080624A JP2025131599A5 JP 2025131599 A5 JP2025131599 A5 JP 2025131599A5 JP 2025080624 A JP2025080624 A JP 2025080624A JP 2025080624 A JP2025080624 A JP 2025080624A JP 2025131599 A5 JP2025131599 A5 JP 2025131599A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antigen
- binding fragment
- targeting antibody
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662413613P | 2016-10-27 | 2016-10-27 | |
| US201662413586P | 2016-10-27 | 2016-10-27 | |
| US62/413,586 | 2016-10-27 | ||
| US62/413,613 | 2016-10-27 | ||
| PCT/US2017/058462 WO2018081375A1 (en) | 2016-10-27 | 2017-10-26 | Immunoglobulins and uses thereof |
| JP2019522246A JP7231539B2 (ja) | 2016-10-27 | 2017-10-26 | 免疫グロブリン及びその使用 |
| JP2022162413A JP7724196B2 (ja) | 2016-10-27 | 2022-10-07 | 免疫グロブリン及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022162413A Division JP7724196B2 (ja) | 2016-10-27 | 2022-10-07 | 免疫グロブリン及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025131599A JP2025131599A (ja) | 2025-09-09 |
| JP2025131599A5 true JP2025131599A5 (cg-RX-API-DMAC10.html) | 2025-12-24 |
Family
ID=62020814
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522246A Active JP7231539B2 (ja) | 2016-10-27 | 2017-10-26 | 免疫グロブリン及びその使用 |
| JP2019522454A Active JP7090077B2 (ja) | 2016-10-27 | 2017-10-26 | 神経ペプチドｙ受容体の調節因子としての環状ペプチドチロシンチロシン化合物 |
| JP2019522221A Active JP7387431B2 (ja) | 2016-10-27 | 2017-10-26 | 神経ペプチドｙ受容体の調節因子としての抗体結合環状ペプチドチロシンチロシン化合物 |
| JP2022095087A Withdrawn JP2022137031A (ja) | 2016-10-27 | 2022-06-13 | 神経ペプチドｙ受容体の調節因子としての環状ペプチドチロシンチロシン化合物 |
| JP2022162413A Active JP7724196B2 (ja) | 2016-10-27 | 2022-10-07 | 免疫グロブリン及びその使用 |
| JP2023194207A Pending JP2024020405A (ja) | 2016-10-27 | 2023-11-15 | 神経ペプチドｙ受容体の調節因子としての抗体結合環状ペプチドチロシンチロシン化合物 |
| JP2025034490A Pending JP2025102780A (ja) | 2016-10-27 | 2025-03-05 | 神経ペプチドｙ受容体の調節因子としての環状ペプチドチロシンチロシン化合物 |
| JP2025080624A Pending JP2025131599A (ja) | 2016-10-27 | 2025-05-13 | 免疫グロブリン及びその使用 |
Family Applications Before (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522246A Active JP7231539B2 (ja) | 2016-10-27 | 2017-10-26 | 免疫グロブリン及びその使用 |
| JP2019522454A Active JP7090077B2 (ja) | 2016-10-27 | 2017-10-26 | 神経ペプチドｙ受容体の調節因子としての環状ペプチドチロシンチロシン化合物 |
| JP2019522221A Active JP7387431B2 (ja) | 2016-10-27 | 2017-10-26 | 神経ペプチドｙ受容体の調節因子としての抗体結合環状ペプチドチロシンチロシン化合物 |
| JP2022095087A Withdrawn JP2022137031A (ja) | 2016-10-27 | 2022-06-13 | 神経ペプチドｙ受容体の調節因子としての環状ペプチドチロシンチロシン化合物 |
| JP2022162413A Active JP7724196B2 (ja) | 2016-10-27 | 2022-10-07 | 免疫グロブリン及びその使用 |
| JP2023194207A Pending JP2024020405A (ja) | 2016-10-27 | 2023-11-15 | 神経ペプチドｙ受容体の調節因子としての抗体結合環状ペプチドチロシンチロシン化合物 |
| JP2025034490A Pending JP2025102780A (ja) | 2016-10-27 | 2025-03-05 | 神経ペプチドｙ受容体の調節因子としての環状ペプチドチロシンチロシン化合物 |
Country Status (39)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10513546B2 (en) | 2013-12-18 | 2019-12-24 | President And Fellows Of Harvard College | CRP capture/detection of gram positive bacteria |
| JOP20190095A1 (ar) * | 2016-10-27 | 2019-04-28 | Janssen Pharmaceutica Nv | مركبات ببتيد تيروسين-تيروسين الحلقية كمعدلات لمستقبلات الببتيد العصبي y |
| US11780900B2 (en) | 2018-04-25 | 2023-10-10 | Janssen Sciences Ireland Unlimited Company | Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof |
| TWI847981B (zh) * | 2018-04-25 | 2024-07-11 | 比利時商健生藥品公司 | 類升糖素肽1 (glp-1)融合肽偶合環狀酪酪肽接合物及其用途 |
| WO2020188510A2 (en) * | 2019-03-19 | 2020-09-24 | Enzene Biosciences Limited | Process of preparation of glucagon-like peptide-1 (glp-1) receptor agonists and their analogs |
| CN114853908B (zh) * | 2019-05-16 | 2024-06-07 | 浙江道尔生物科技有限公司 | 一种治疗代谢疾病的融合蛋白 |
| WO2020262590A1 (ja) * | 2019-06-28 | 2020-12-30 | 味の素株式会社 | 環状ペプチドの製造方法 |
| KR20220100925A (ko) | 2019-11-11 | 2022-07-18 | 베링거 인겔하임 인터내셔날 게엠베하 | Npy2 수용체 작용제 |
| EP4069726A4 (en) * | 2019-12-04 | 2024-03-20 | The Scripps Research Institute | GLP2 RECEPTOR AGONISTS AND METHOD OF USE |
| CN111494606B (zh) * | 2020-04-24 | 2021-12-14 | 广州医科大学 | 神经肽y的新应用 |
| WO2022029231A1 (en) | 2020-08-07 | 2022-02-10 | Boehringer Ingelheim International Gmbh | Soluble npy2 receptor agonists |
| EP4288078A4 (en) * | 2021-02-03 | 2024-12-11 | Sun Pharmaceutical Industries Ltd | READY-TO-USE OXYTOCIN DOSAGE FORM |
| CN115073556A (zh) * | 2021-03-12 | 2022-09-20 | 上海天慈生命科学发展有限公司 | 一类阿片/神经肽ff受体多靶点环肽分子及其制备和应用 |
| BR112023026286A2 (pt) * | 2021-06-14 | 2024-03-05 | Darbix Llc | Agonistas do receptor de glp-1 com propriedades farmacológicas e de liberação de fármacos melhoradas |
| KR20230004135A (ko) * | 2021-06-30 | 2023-01-06 | 한미약품 주식회사 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체를 포함하는 조합물의 치료학적 용도 |
| WO2023097363A1 (en) * | 2021-11-30 | 2023-06-08 | Garvan Institute Of Medical Research | Improved binding proteins and uses thereof |
| CN115028551B (zh) * | 2022-07-15 | 2024-01-05 | 成都普康生物科技有限公司 | 一种叠氮-九甘醇-丙酸的制备方法 |
| CN116098987A (zh) * | 2023-02-09 | 2023-05-12 | 华东医院 | 甘丙肽在制备治疗非酒精性脂肪性肝病药物中的用途 |
| CN117924142A (zh) * | 2024-01-19 | 2024-04-26 | 成都普康生物科技有限公司 | 司美格鲁肽侧链的液相合成方法和司美格鲁肽的合成方法 |
| WO2025252023A1 (en) * | 2024-06-03 | 2025-12-11 | Fortvita Biologics Inc. | Modulators for gipr, glp1r and/or gcgr and uses thereof |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2434149A1 (fr) | 1978-06-22 | 1980-03-21 | Parcor | Nouveaux derives de la l-cysteine |
| US5393669A (en) | 1993-02-05 | 1995-02-28 | Martek Biosciences Corp. | Compositions and methods for protein structural determinations |
| US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| EP1789440A4 (en) | 2004-02-11 | 2008-03-12 | Amylin Pharmaceuticals Inc | REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM |
| EP1718671A2 (en) * | 2004-02-23 | 2006-11-08 | Rheoscience A/S | Peptide yy analogues |
| EP2272524A3 (en) * | 2004-03-17 | 2011-02-02 | 7TM Pharma A/S | Y2 selective receptor agonists for therapeutic interventions |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| TR201808537T4 (tr) * | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| EP2471810A1 (en) | 2006-02-22 | 2012-07-04 | Merck Sharp & Dohme Corporation | Oxyntomodulin derivatives |
| AU2007227202B2 (en) * | 2006-03-21 | 2013-08-22 | Amylin Pharmaceuticals, Llc | Peptide-peptidase inhibitor conjugates and methods of using same |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| BRPI0718225A2 (pt) | 2006-10-05 | 2013-11-12 | Centocor Ortho Biotech Inc | Antagonistas de ccr2 para tratamento de fibrose |
| JP2008169195A (ja) * | 2007-01-05 | 2008-07-24 | Hanmi Pharmaceutical Co Ltd | キャリア物質を用いたインスリン分泌ペプチド薬物結合体 |
| EP2527369A3 (en) | 2007-09-13 | 2012-12-19 | University Of Zurich Prorektorat Forschung | Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| BRPI0921640A2 (pt) | 2008-11-04 | 2019-09-24 | Janssen Pharmaceutica Nv | agonistas peptídicos do crhr2 e usos do mesmo |
| BRPI0921230A2 (pt) * | 2008-11-05 | 2018-10-30 | Hoffmann La Roche | agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo. |
| US9067986B2 (en) | 2009-04-27 | 2015-06-30 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| JP6054742B2 (ja) | 2009-07-13 | 2016-12-27 | ジーランド ファーマ アクティーゼルスカブ | アシル化グルカゴン類似体 |
| CN102573888A (zh) | 2009-09-18 | 2012-07-11 | 诺和诺德公司 | 长效y2 受体激动剂 |
| KR20120092611A (ko) | 2009-09-30 | 2012-08-21 | 글락소 그룹 리미티드 | 연장된 반감기를 갖는 약물 융합체 및 컨쥬게이트 |
| KR20130018410A (ko) * | 2010-03-26 | 2013-02-21 | 노보 노르디스크 에이/에스 | 새로운 글루카곤 유사체 |
| PT2560993T (pt) | 2010-04-20 | 2024-09-16 | Genmab As | Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas |
| US8906649B2 (en) * | 2010-09-27 | 2014-12-09 | Janssen Biotech, Inc. | Antibodies binding human collagen II |
| EP2621950A4 (en) | 2010-09-27 | 2015-09-02 | Janssen Biotech Inc | ANTIBODIES FOR BINDING HUMAN COLLAGEN II |
| CN103429620B (zh) | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| CA2825778A1 (en) * | 2011-01-28 | 2012-08-02 | Sanofi | Pharmaceutical compositions comprising human antibodies to pcsk9 |
| TWI601744B (zh) * | 2011-06-17 | 2017-10-11 | 韓美科學股份有限公司 | 包含調酸素與免疫球蛋白片段之複合物及其用途 |
| US9574010B2 (en) | 2011-11-04 | 2017-02-21 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
| SG11201407420RA (en) * | 2012-07-04 | 2015-02-27 | Hoffmann La Roche | Covalently linked antigen-antibody conjugates |
| EA039082B1 (ru) * | 2012-11-06 | 2021-12-01 | Ханми Фарм. Ко., Лтд. | Жидкая композиция белкового конъюгата, содержащего оксинтомодулин и фрагмент иммуноглобулина |
| SG11201504920SA (en) | 2012-12-27 | 2015-07-30 | Sanofi Sa | Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof |
| EP2943512A4 (en) | 2013-01-11 | 2016-06-01 | California Inst Biomedical Res | BOVINE FUSION ANTIBODY |
| EP2992008B1 (en) | 2013-05-02 | 2019-04-10 | GlaxoSmithKline Intellectual Property Development Limited | Therapeutic peptides |
| ES2719584T3 (es) * | 2014-04-11 | 2019-07-11 | Medimmune Llc | Compuestos conjugados que comprenden anticuerpos modificados por ingeniería genética con cisteína |
| AR100978A1 (es) * | 2014-06-26 | 2016-11-16 | Hoffmann La Roche | LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS |
| JP6704358B2 (ja) | 2014-07-30 | 2020-06-03 | エヌジーエム バイオファーマシューティカルズ インコーポレイテッド | 代謝障害を治療するための組成物および使用方法 |
| BR112018008908A2 (pt) * | 2015-11-02 | 2018-11-27 | Janssen Pharmaceutica Nv | anticorpos anti-il1rap, moléculas de ligação ao antígeno biespecíficas que se ligam il1rap e cd3, e seus usos |
| JOP20190095A1 (ar) * | 2016-10-27 | 2019-04-28 | Janssen Pharmaceutica Nv | مركبات ببتيد تيروسين-تيروسين الحلقية كمعدلات لمستقبلات الببتيد العصبي y |
| TWI847981B (zh) * | 2018-04-25 | 2024-07-11 | 比利時商健生藥品公司 | 類升糖素肽1 (glp-1)融合肽偶合環狀酪酪肽接合物及其用途 |
-
2017
- 2017-06-16 JO JOP/2019/0095A patent/JOP20190095A1/ar unknown
- 2017-10-26 US US15/794,250 patent/US10428134B2/en active Active
- 2017-10-26 EP EP17865051.1A patent/EP3534928A4/en active Pending
- 2017-10-26 CA CA3041674A patent/CA3041674A1/en active Pending
- 2017-10-26 US US15/794,231 patent/US10968264B2/en active Active
- 2017-10-26 KR KR1020237029347A patent/KR102704251B1/ko active Active
- 2017-10-26 IL IL266202A patent/IL266202B2/en unknown
- 2017-10-26 JP JP2019522246A patent/JP7231539B2/ja active Active
- 2017-10-26 US US15/794,171 patent/US10640544B2/en active Active
- 2017-10-26 ES ES21198106T patent/ES3025907T3/es active Active
- 2017-10-26 CN CN201780066841.4A patent/CN110099692B/zh active Active
- 2017-10-26 UY UY0001037456A patent/UY37456A/es active IP Right Grant
- 2017-10-26 CA CA3041046A patent/CA3041046A1/en active Pending
- 2017-10-26 WO PCT/US2017/058455 patent/WO2018081370A1/en not_active Ceased
- 2017-10-26 SG SG11201902873RA patent/SG11201902873RA/en unknown
- 2017-10-26 RS RS20211419A patent/RS62677B1/sr unknown
- 2017-10-26 TW TW106136950A patent/TWI794189B/zh active
- 2017-10-26 PE PE2019000865A patent/PE20191079A1/es unknown
- 2017-10-26 UY UY0001037457A patent/UY37457A/es active IP Right Grant
- 2017-10-26 TW TW106136953A patent/TWI781118B/zh active
- 2017-10-26 CR CR20190208A patent/CR20190208A/es unknown
- 2017-10-26 CN CN201780066833.XA patent/CN110036022A/zh active Pending
- 2017-10-26 SG SG11201902886SA patent/SG11201902886SA/en unknown
- 2017-10-26 CN CN202410186893.7A patent/CN118085061A/zh active Pending
- 2017-10-26 HU HUE17864112A patent/HUE056442T2/hu unknown
- 2017-10-26 IL IL266204A patent/IL266204B2/en unknown
- 2017-10-26 US US16/344,263 patent/US10858413B2/en active Active
- 2017-10-26 EP EP17863347.5A patent/EP3532092B1/en active Active
- 2017-10-26 PL PL17864112T patent/PL3532486T3/pl unknown
- 2017-10-26 MX MX2019004952A patent/MX2019004952A/es unknown
- 2017-10-26 KR KR1020197015098A patent/KR102573684B1/ko active Active
- 2017-10-26 BR BR112019008351-0A patent/BR112019008351A2/pt not_active Application Discontinuation
- 2017-10-26 EP EP21198106.3A patent/EP3988123B1/en active Active
- 2017-10-26 IL IL314935A patent/IL314935A/en unknown
- 2017-10-26 CR CR20190210A patent/CR20190210A/es unknown
- 2017-10-26 AU AU2017348172A patent/AU2017348172B2/en active Active
- 2017-10-26 PE PE2019000881A patent/PE20190917A1/es unknown
- 2017-10-26 SG SG10202107777XA patent/SG10202107777XA/en unknown
- 2017-10-26 EP EP25160021.9A patent/EP4574166A3/en not_active Withdrawn
- 2017-10-26 US US16/344,174 patent/US10968265B2/en active Active
- 2017-10-26 HR HRP20211626TT patent/HRP20211626T1/hr unknown
- 2017-10-26 MX MX2019004954A patent/MX2019004954A/es unknown
- 2017-10-26 MY MYPI2022001424A patent/MY199449A/en unknown
- 2017-10-26 KR KR1020197015097A patent/KR102653381B1/ko active Active
- 2017-10-26 TW TW111126993A patent/TW202304972A/zh unknown
- 2017-10-26 MA MA46665A patent/MA46665B1/fr unknown
- 2017-10-26 PE PE2019000878A patent/PE20190916A1/es unknown
- 2017-10-26 AU AU2017348175A patent/AU2017348175B2/en active Active
- 2017-10-26 US US16/344,141 patent/US10961293B2/en active Active
- 2017-10-26 MD MDE20190989T patent/MD3532486T2/ro unknown
- 2017-10-26 CR CR20190209A patent/CR20190209A/es unknown
- 2017-10-26 ES ES17864112T patent/ES2897480T3/es active Active
- 2017-10-26 BR BR112019008417-7A patent/BR112019008417A2/pt active Search and Examination
- 2017-10-26 WO PCT/US2017/058451 patent/WO2018081367A1/en not_active Ceased
- 2017-10-26 TW TW106136948A patent/TWI773699B/zh active
- 2017-10-26 KR KR1020247010321A patent/KR20240046290A/ko not_active Ceased
- 2017-10-26 MY MYPI2019002333A patent/MY199666A/en unknown
- 2017-10-26 AU AU2017348180A patent/AU2017348180B2/en active Active
- 2017-10-26 PT PT178641122T patent/PT3532486T/pt unknown
- 2017-10-26 MX MX2019004955A patent/MX2019004955A/es unknown
- 2017-10-26 IL IL301843A patent/IL301843B2/en unknown
- 2017-10-26 MA MA046718A patent/MA46718A/fr unknown
- 2017-10-26 WO PCT/US2017/058462 patent/WO2018081375A1/en not_active Ceased
- 2017-10-26 KR KR1020197015094A patent/KR102653376B1/ko active Active
- 2017-10-26 KR KR1020247010337A patent/KR20240046621A/ko not_active Ceased
- 2017-10-26 SM SM20210647T patent/SMT202100647T1/it unknown
- 2017-10-26 CN CN201780066750.0A patent/CN109890410A/zh active Pending
- 2017-10-26 EP EP17864112.2A patent/EP3532486B8/en active Active
- 2017-10-26 SG SG11201902879SA patent/SG11201902879SA/en unknown
- 2017-10-26 UY UY0001037455A patent/UY37455A/es unknown
- 2017-10-26 CA CA3041672A patent/CA3041672A1/en active Pending
- 2017-10-26 JO JOP/2019/0096A patent/JOP20190096B1/ar active
- 2017-10-26 MA MA046672A patent/MA46672A/fr unknown
- 2017-10-26 SI SI201730982T patent/SI3532486T1/sl unknown
- 2017-10-26 BR BR112019008500-9A patent/BR112019008500A2/pt unknown
- 2017-10-26 DK DK17864112.2T patent/DK3532486T3/da active
- 2017-10-26 JP JP2019522454A patent/JP7090077B2/ja active Active
- 2017-10-26 IL IL266206A patent/IL266206B2/en unknown
- 2017-10-26 JP JP2019522221A patent/JP7387431B2/ja active Active
- 2017-10-26 LT LTEPPCT/US2017/058455T patent/LT3532486T/lt unknown
-
2019
- 2019-04-03 PH PH12019500723A patent/PH12019500723A1/en unknown
- 2019-04-05 PH PH12019500749A patent/PH12019500749A1/en unknown
- 2019-04-17 CO CONC2019/0003938A patent/CO2019003938A2/es unknown
- 2019-04-23 CL CL2019001110A patent/CL2019001110A1/es unknown
- 2019-04-24 CL CL2019001129A patent/CL2019001129A1/es unknown
- 2019-04-24 SA SA519401646A patent/SA519401646B1/ar unknown
- 2019-04-24 SA SA519401642A patent/SA519401642B1/ar unknown
- 2019-04-24 SA SA519401647A patent/SA519401647B1/ar unknown
- 2019-04-24 PH PH12019500906A patent/PH12019500906A1/en unknown
- 2019-04-25 CL CL2019001136A patent/CL2019001136A1/es unknown
- 2019-04-25 DO DO2019000107A patent/DOP2019000107A/es unknown
- 2019-04-25 DO DO2019000106A patent/DOP2019000106A/es unknown
- 2019-04-26 NI NI201900043A patent/NI201900043A/es unknown
- 2019-04-26 EC ECSENADI201929942A patent/ECSP19029942A/es unknown
- 2019-04-26 MX MX2024001845A patent/MX2024001845A/es unknown
- 2019-04-26 CO CONC2019/0004186A patent/CO2019004186A2/es unknown
- 2019-04-26 MX MX2023005465A patent/MX2023005465A/es unknown
- 2019-04-26 CO CONC2019/0004203A patent/CO2019004203A2/es unknown
- 2019-04-26 NI NI201900044A patent/NI201900044A/es unknown
- 2019-04-26 MX MX2023014354A patent/MX2023014354A/es unknown
- 2019-04-26 EC ECSENADI201929995A patent/ECSP19029995A/es unknown
- 2019-04-26 EC ECSENADI201929835A patent/ECSP19029835A/es unknown
- 2019-04-28 JO JOP/2019/0097A patent/JOP20190097A1/ar unknown
- 2019-07-04 DO DO2019000178A patent/DOP2019000178A/es unknown
- 2019-08-16 US US16/542,751 patent/US10787495B2/en active Active
-
2020
- 2020-03-16 US US16/820,174 patent/US11591379B2/en active Active
- 2020-08-21 US US16/947,875 patent/US11401315B2/en active Active
- 2020-10-30 US US17/085,128 patent/US12134636B2/en active Active
-
2021
- 2021-02-05 US US17/168,503 patent/US11767354B2/en active Active
- 2021-02-05 US US17/168,325 patent/US11732019B2/en active Active
- 2021-11-11 CY CY20211100986T patent/CY1124732T1/el unknown
- 2021-11-19 AU AU2021269420A patent/AU2021269420B2/en active Active
-
2022
- 2022-01-07 AU AU2022200089A patent/AU2022200089B2/en active Active
- 2022-01-13 ZA ZA2022/00648A patent/ZA202200648B/en unknown
- 2022-06-13 JP JP2022095087A patent/JP2022137031A/ja not_active Withdrawn
- 2022-10-07 JP JP2022162413A patent/JP7724196B2/ja active Active
-
2023
- 2023-01-12 US US18/154,020 patent/US20230365644A1/en active Pending
- 2023-06-28 US US18/343,689 patent/US20240018208A1/en active Pending
- 2023-11-15 JP JP2023194207A patent/JP2024020405A/ja active Pending
-
2024
- 2024-08-07 IL IL314808A patent/IL314808B2/en unknown
- 2024-10-02 US US18/904,962 patent/US20250026803A1/en active Pending
-
2025
- 2025-03-05 JP JP2025034490A patent/JP2025102780A/ja active Pending
- 2025-03-07 AU AU2025201677A patent/AU2025201677A1/en active Pending
- 2025-05-13 JP JP2025080624A patent/JP2025131599A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL314935A (en) | Immunoglobulins and their uses | |
| CN103402545B (zh) | 疏水性经修饰肽及其在肝特异性靶向中的用途 | |
| CN101128487B (zh) | 靶向血清白蛋白和glp-1或pyy的双特异性结构域抗体 | |
| US8906847B2 (en) | Prodrug comprising a drug linker conjugate | |
| US20130078216A1 (en) | Liver targeting molecules | |
| CN103261224B (zh) | 用于肝癌治疗的方法和组合物 | |
| CN105061593B (zh) | 改良的抗血清清蛋白结合变体 | |
| CN111620945A (zh) | 一种抗新型冠状病毒的单克隆抗体或其衍生体 | |
| US20110020345A1 (en) | Drug fusions and conjugates | |
| MD3570885T2 (ro) | Metodă de tratare sau ameliorare a tulburărilor metabolice utilizând agoniști ai receptorului GLP-1 conjugați cu antagoniști pentru receptorul polipeptidei inhibitoare gastrice (GIPR) | |
| AU2005250216A1 (en) | Bispecific fusion antibodies with enhanced serum half-life | |
| CA2663042A1 (en) | Serum albumin binding proteins with long half-lives | |
| CN106795214B (zh) | 稳定化的基于纤连蛋白的支架分子 | |
| WO2008049897A1 (en) | Intranasal delivery of polypeptides and proteins | |
| JP2022513363A5 (cg-RX-API-DMAC10.html) | ||
| WO2022111616A1 (zh) | 抗cldn18.2抗体、药物偶联物及其制备方法和用途 | |
| EP2493504B1 (en) | Stable anti-tnfr1 polypeptides, antibody variable domains and antagonists | |
| US20210300995A1 (en) | Long-acting fibronectin type III domain fusion protein | |
| EP3969125A1 (en) | Use of anti-fcrn antibodies in the treatment of pemphighus and pemphigoid diseases | |
| US8258257B2 (en) | Claudin-4 binding peptides, compositions and methods of use | |
| WO2017211278A1 (en) | Antibody fusion proteins for drug delivery | |
| CN102257009A (zh) | 具有针对dc-sign的结合特异性的配体 | |
| CN118005780A (zh) | 一种靶向猪流行性腹泻病毒rbd的纳米抗体及其应用 | |
| US20120058116A1 (en) | Fgfr1c antibody combinations | |
| CN119119273B (zh) | 结合C5aR2膜蛋白的抗体及其制备方法 |